Allergy & Asthma Network Mothers of Asthmatics (AANMA)

Freedom to Breathe Act Won’t Help Patients, AANMA Says

Published November - 3 - 2011 Print This Post

A new bill from U.S. Senator Pat Roberts (R-KS) as well as an amendment by Senator Jim DeMint (R-SC) to separate legislation seek to allow epinephrine inhalers that contain chlorofluorocarbon (CFC) propellants to stay on the market, rather than being removed as agreed to in an international treaty ratified by all U.N.-recognized nations. AANMA and a group of patient advocacy and medical professional organizations wrote the senators late last week to explain that this exception wouldn’t benefit patients with asthma and suggest alternative ways to help.

Click here to read AANMA’s press release.

Click here to read the letter to Sens. Roberts and DeMint in its entirety.